Alkermes (ALKS) News Today $32.17 +0.96 (+3.08%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$32.34 +0.17 (+0.53%) As of 10/13/2025 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALKS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Brokerages Set Alkermes plc (NASDAQ:ALKS) Price Target at $42.00October 10, 2025 | americanbankingnews.comRobeco Institutional Asset Management B.V. Buys 36,467 Shares of Alkermes plc $ALKSOctober 7, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Given Average Rating of "Moderate Buy" by AnalystsOctober 7, 2025 | marketbeat.comAlkermes sued over alleged scheme to block generic VivitrolOctober 3, 2025 | reuters.comWells Fargo Sticks to Its Buy Rating for Alkermes (ALKS)October 3, 2025 | theglobeandmail.comAlkermes, Centessa added to Q4 2025 Tactical Ideas List at Wells FargoOctober 1, 2025 | msn.comIs Alkermes' (ALKS) Narcolepsy Drug Breakthrough Shifting Its Investment Narrative?September 29, 2025 | finance.yahoo.comAssessing Alkermes (ALKS) Valuation as Investors Reconsider the Growth StorySeptember 27, 2025 | finance.yahoo.com9 Analysts Assess Alkermes: What You Need To KnowSeptember 26, 2025 | benzinga.comAlkermes upgraded to Outperform from Sector Perform at RBC CapitalSeptember 26, 2025 | msn.comAlkermes upgraded at RBC Capital Markets ahead of key catalystSeptember 26, 2025 | msn.comRBC Capital Upgrades Alkermes (ALKS)September 26, 2025 | msn.comAlkermes (NASDAQ:ALKS) Shares Gap Up After Analyst UpgradeSeptember 26, 2025 | marketbeat.comAlkermes (NASDAQ:ALKS) Upgraded by Royal Bank Of Canada to "Outperform" RatingSeptember 26, 2025 | marketbeat.comAssenagon Asset Management S.A. Has $2.40 Million Position in Alkermes plc $ALKSSeptember 26, 2025 | marketbeat.comOliver Luxxe Assets LLC Makes New Investment in Alkermes plc $ALKSSeptember 23, 2025 | marketbeat.comWedge Capital Management L L P NC Increases Stock Position in Alkermes plc $ALKSSeptember 22, 2025 | marketbeat.comAtle Fund Management AB Has $6.50 Million Stake in Alkermes plc $ALKSSeptember 21, 2025 | marketbeat.comHC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 StudySeptember 18, 2025 | finance.yahoo.comStrs Ohio Buys Shares of 42,500 Alkermes plc $ALKSSeptember 18, 2025 | marketbeat.comAlkermes plc $ALKS Shares Purchased by Voya Investment Management LLCSeptember 17, 2025 | marketbeat.comAlkermes plc $ALKS Shares Acquired by Intech Investment Management LLCSeptember 16, 2025 | marketbeat.comAmundi Cuts Holdings in Alkermes plc $ALKSSeptember 14, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 14, 2025 | marketbeat.comAcadian Asset Management LLC Has $29.10 Million Position in Alkermes plc $ALKSSeptember 13, 2025 | marketbeat.comBaird Financial Group Inc. Purchases New Shares in Alkermes plc $ALKSSeptember 13, 2025 | marketbeat.comAlkermes names Joshua Reed as CFOSeptember 12, 2025 | msn.comAlkermes Appoints Joshua Reed as New CFOSeptember 12, 2025 | tipranks.comAlkermes Appoints Joshua Reed as Chief Financial OfficerSeptember 12, 2025 | prnewswire.comFred Alger Management LLC Takes $1.24 Million Position in Alkermes plc $ALKSSeptember 12, 2025 | marketbeat.comAQR Capital Management LLC Sells 279,276 Shares of Alkermes plc $ALKSSeptember 12, 2025 | marketbeat.comAlkermes (NASDAQ:ALKS) Price Target Raised to $35.00September 11, 2025 | marketbeat.comAlkermes plc: Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards ProgramSeptember 11, 2025 | finanznachrichten.deAlkermes' (ALKS) Neutral Rating Reiterated at HC WainwrightSeptember 11, 2025 | marketbeat.comAlkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® ProgramSeptember 11, 2025 | prnewswire.comAlkermes Target of Unusually High Options Trading (NASDAQ:ALKS)September 10, 2025 | marketbeat.comAlkermes (NASDAQ:ALKS) Hits New 12-Month Low - What's Next?September 10, 2025 | marketbeat.comAlkermes price target lowered to $43 from $45 at NeedhamSeptember 10, 2025 | msn.comAlkermes price target raised to $35 from $34 at JPMorganSeptember 10, 2025 | msn.comAlkermes narcolepsy type 1 data largely as expected, says MizuhoSeptember 8, 2025 | msn.comAlkermes narcolepsy data ‘solid,’ about as expected, says LeerinkSeptember 8, 2025 | msn.comAlkermes Plc (ALKS) World Sleep Congress 2025 (Transcript)September 8, 2025 | seekingalpha.comAlkermes plc (ALKS) World Sleep Congress 2025September 8, 2025 | seekingalpha.comAlkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025September 8, 2025 | prnewswire.comAlkermes (NASDAQ:ALKS) Upgraded at Wells Fargo & CompanySeptember 6, 2025 | marketbeat.comAlkermes (NASDAQ:ALKS) Trading 7.2% Higher - Should You Buy?September 5, 2025 | marketbeat.comCanada Pension Plan Investment Board Purchases 9,900 Shares of Alkermes plc $ALKSSeptember 5, 2025 | marketbeat.comWells Fargo Initiates a Buy Rating on Alkermes (ALKS)September 4, 2025 | theglobeandmail.comMPM Bioimpact LLC Acquires Shares of 337,603 Alkermes plc $ALKSSeptember 4, 2025 | marketbeat.comPalo Alto Investors LP Decreases Holdings in Alkermes plc $ALKSSeptember 4, 2025 | marketbeat.com Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALKS Media Mentions By Week ALKS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALKS News Sentiment▼1.200.75▲Average Medical News Sentiment ALKS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALKS Articles This Week▼49▲ALKS Articles Average Week Get the Latest News and Ratings for ALKS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alkermes and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Abeona Therapeutics News Medpace News Omnicell News AMN Healthcare Services News United Therapeutics News Incyte News Neurocrine Biosciences News Ionis Pharmaceuticals News Exact Sciences News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALKS) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alkermes plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alkermes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
